Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Inv. presentation

PMV Pharmaceuticals, Inc. (PMVP) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/12/2023 8-K Quarterly results
10/11/2023 8-K Quarterly results
08/23/2023 SC 13D/A ORBIMED ADVISORS LLC reports a 13.5% stake in PMV Pharmaceuticals, Inc.
08/09/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/09/2023 8-K Quarterly results
08/08/2023 4 Mack David Henry (President and CEO) has filed a Form 4 on PMV Pharmaceuticals, Inc.
Txns: Exercised 85,500 options to buy @ $0.53, valued at $45.3k
07/07/2023 SC 13G/A BlackRock Inc. reports a 10.2% stake in PMV PHARMACEUTICALS, INC.
06/12/2023 4 Stelzer Laurie (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.
Txns: Granted 21,500 options to buy @ $5.59, valued at $120.2k
06/12/2023 4 LEVINE ARNOLD J (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.
Txns: Granted 21,500 options to buy @ $5.59, valued at $120.2k
06/12/2023 4 Heyman Richard A. (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.
Txns: Granted 21,500 options to buy @ $5.59, valued at $120.2k
06/12/2023 4 Gallagher Carol Giltner (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.
Txns: Granted 21,500 options to buy @ $5.59, valued at $120.2k
Gifted 21,500 options to buy @ $5.59, valued at $120.2k
Gifted 21,500 options to buy @ $5.59, valued at $120.2k
06/12/2023 4 FLOWERS KIRSTEN (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.
Txns: Granted 21,500 options to buy @ $5.59, valued at $120.2k
06/12/2023 4 BAUM CHARLES M (Director) has filed a Form 4 on PMV Pharmaceuticals, Inc.
Txns: Granted 21,500 options to buy @ $5.59, valued at $120.2k
06/09/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/19/2023 SC 13G CITADEL ADVISORS LLC reports a 4.9% stake in PMV Pharmaceuticals, Inc.
05/15/2023 4 Jalota Deepika (Chief Development Officer) has filed a Form 4 on PMV Pharmaceuticals, Inc.
Txns: Granted 125,000 options to buy @ $5.7, valued at $712.5k
05/15/2023 4 Alland Leila (Chief Medical Officer) has filed a Form 4 on PMV Pharmaceuticals, Inc.
Txns: Granted 100,000 options to buy @ $5.7, valued at $570k
05/15/2023 4 Kung Winston (COO, CFO) has filed a Form 4 on PMV Pharmaceuticals, Inc.
Txns: Granted 150,000 options to buy @ $5.7, valued at $855k
05/15/2023 4 Mack David Henry (President and CEO) has filed a Form 4 on PMV Pharmaceuticals, Inc.
Txns: Granted 330,000 options to buy @ $5.7, valued at $1.9M
05/10/2023 SC 13G/A STATE STREET CORP reports a 1.4% stake in EXIT FILING PMV PHARMACEUTICALS INC
05/10/2023 10-Q Quarterly Report for the period ended March 31, 2023
05/10/2023 8-K Quarterly results
Docs: "PMV Pharmaceuticals, Inc. Balance Sheets March 31,2023"
05/01/2023 EFFECT Form EFFECT - Notice of Effectiveness:
04/28/2023 ARS Form ARS - Annual Report to Security Holders:
04/28/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/28/2023 8-K Quarterly results
04/28/2023 DEF 14A Form DEF 14A - Other definitive proxy statements:
03/01/2023 POS AM Form POS AM - Post-Effective amendments for registration statement:
03/01/2023 10-K Annual Report for the period ended December 31, 2022
03/01/2023 8-K Quarterly results
03/01/2023 POSASR Form POSASR - Post-effective Amendment to an automatic shelf registration statement:
02/14/2023 SC 13G/A Boxer Capital, LLC reports a 6.9% stake in PMV Pharmaceuticals, Inc.
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/14/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy